[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.203.245.76. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 777
Citations 0
News From the Food and Drug Administration
December 18, 2018

Rapid Ebola Test Uses Micro Reader to Improve Accuracy

JAMA. 2018;320(23):2413. doi:10.1001/jama.2018.19379

Instead of being read visually like some rapid diagnostic tests for Ebola virus, a newly authorized test is the first to use a portable, battery-operated micro reader to reduce the risk of human error in interpreting test results.

The DPP Ebola Antigen System detects viral antigens and provides results in 15 to 20 minutes. It is authorized for use with whole blood from a fingerstick, EDTA venous whole blood, and EDTA plasma. The test should be used in conjunction with other factors such as signs and symptoms of infection or living in a geographic area where Ebola infection prevalence is high.

×